Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Chowdhury

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
The Journal of the British Menopause Society|September 7, 2006
Adjuvant aromatase inhibitors and bone healthSimon Chowdhury, Lisa M Pickering, Paul A Ellis
The Practitioner|November 5, 2015
New developments in metastatic prostate cancer therapyThubeena Manickavasagar, Clare Gilson, Simon Chowdhury, et al.
Clinical Nephrology|February 1, 2013
Advanced native kidney renal cell carcinoma in renal transplant recipients: role of sirolimus as dual anti-cancer and anti-rejection agentMuhammad M Javaid, Simon Chowdhury, Alastair Henderson, et al.
Nature Clinical Practice. Oncology|July 28, 2007
Drug insight: advances in renal cell carcinoma and the role of targeted therapiesJames M G Larkin, Simon Chowdhury, Martin E Gore
Cancers|February 15, 2022
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?Eric Jonasch, Michael B Atkins, Simon Chowdhury, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2008
Recent advances in the treatment of renal cell carcinoma and the role of targeted therapiesSimon Chowdhury, James M G Larkin, Martin E Gore
Expert Review of Anticancer Therapy|June 22, 2012
Neoadjuvant and adjuvant treatment of renal cell carcinomaKiruthikah Thillai, Suzanne Allan, Thomas Powles, et al.
Expert Review of Anticancer Therapy|October 30, 2014
'Charting a new course for prostate cancer' - currying favor for docetaxel in hormone-sensitive metastatic prostate cancerMark Voskoboynik, John Staffurth, Zafar Malik, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
Cancer Treatment Reviews|August 21, 2013
Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agentsAmit Bahl, Susan Masson, Alison Birtle, et al.
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
The Journal of the British Menopause Society|September 7, 2006
Adjuvant aromatase inhibitors and bone healthSimon Chowdhury, Lisa M Pickering, Paul A Ellis
The Practitioner|November 5, 2015
New developments in metastatic prostate cancer therapyThubeena Manickavasagar, Clare Gilson, Simon Chowdhury, et al.
Clinical Nephrology|February 1, 2013
Advanced native kidney renal cell carcinoma in renal transplant recipients: role of sirolimus as dual anti-cancer and anti-rejection agentMuhammad M Javaid, Simon Chowdhury, Alastair Henderson, et al.
Nature Clinical Practice. Oncology|July 28, 2007
Drug insight: advances in renal cell carcinoma and the role of targeted therapiesJames M G Larkin, Simon Chowdhury, Martin E Gore
Cancers|February 15, 2022
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?Eric Jonasch, Michael B Atkins, Simon Chowdhury, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2008
Recent advances in the treatment of renal cell carcinoma and the role of targeted therapiesSimon Chowdhury, James M G Larkin, Martin E Gore
Expert Review of Anticancer Therapy|June 22, 2012
Neoadjuvant and adjuvant treatment of renal cell carcinomaKiruthikah Thillai, Suzanne Allan, Thomas Powles, et al.
Expert Review of Anticancer Therapy|October 30, 2014
'Charting a new course for prostate cancer' - currying favor for docetaxel in hormone-sensitive metastatic prostate cancerMark Voskoboynik, John Staffurth, Zafar Malik, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
Cancer Treatment Reviews|August 21, 2013
Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agentsAmit Bahl, Susan Masson, Alison Birtle, et al.
Pageof 16